Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 USD | +3.45% | -0.55% | -20.00% |
05-13 | Oppenheimer Adjusts Vor Biopharma Price Target to $10 From $15, Maintains Outperform Rating | MT |
05-09 | Vor Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.00% | 123M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+50.47% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- VOR Stock
- News Vor Biopharma Inc.
- Goldman Sachs Starts Vor Biopharma at Neutral With $6 Price Target